Biorestorative Therapies (BRTX) Competitors $1.59 +0.05 (+3.25%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.60 +0.01 (+0.94%) As of 07/16/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BRTX vs. OPGN, PIII, BDSX, BNR, BMGL, CCM, MRAI, ENZ, BGLC, and MGRXShould you be buying Biorestorative Therapies stock or one of its competitors? The main competitors of Biorestorative Therapies include OpGen (OPGN), P3 Health Partners (PIII), Biodesix (BDSX), Burning Rock Biotech (BNR), Basel Medical Group (BMGL), Concord Medical Services (CCM), Marpai (MRAI), Enzo Biochem (ENZ), BioNexus Gene Lab (BGLC), and Mangoceuticals (MGRX). These companies are all part of the "healthcare" industry. Biorestorative Therapies vs. Its Competitors OpGen P3 Health Partners Biodesix Burning Rock Biotech Basel Medical Group Concord Medical Services Marpai Enzo Biochem BioNexus Gene Lab Mangoceuticals OpGen (NASDAQ:OPGN) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership. Which has more risk & volatility, OPGN or BRTX? OpGen has a beta of -1.66, meaning that its stock price is 266% less volatile than the S&P 500. Comparatively, Biorestorative Therapies has a beta of 75.28, meaning that its stock price is 7,428% more volatile than the S&P 500. Does the media refer more to OPGN or BRTX? In the previous week, Biorestorative Therapies had 3 more articles in the media than OpGen. MarketBeat recorded 3 mentions for Biorestorative Therapies and 0 mentions for OpGen. Biorestorative Therapies' average media sentiment score of 0.84 beat OpGen's score of 0.00 indicating that Biorestorative Therapies is being referred to more favorably in the news media. Company Overall Sentiment OpGen Neutral Biorestorative Therapies Positive Do insiders & institutionals hold more shares of OPGN or BRTX? 2.7% of OpGen shares are owned by institutional investors. Comparatively, 69.4% of Biorestorative Therapies shares are owned by institutional investors. 43.8% of OpGen shares are owned by insiders. Comparatively, 25.5% of Biorestorative Therapies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts rate OPGN or BRTX? Biorestorative Therapies has a consensus price target of $18.00, suggesting a potential upside of 1,032.08%. Given Biorestorative Therapies' stronger consensus rating and higher probable upside, analysts clearly believe Biorestorative Therapies is more favorable than OpGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OpGen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biorestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings & valuation, OPGN or BRTX? Biorestorative Therapies has lower revenue, but higher earnings than OpGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOpGen$2.67M17.33-$32.67MN/AN/ABiorestorative Therapies$400K29.81-$8.98M-$1.47-1.08 Is OPGN or BRTX more profitable? OpGen has a net margin of -1,140.36% compared to Biorestorative Therapies' net margin of -3,093.61%. OpGen's return on equity of 0.00% beat Biorestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets OpGen-1,140.36% N/A -287.58% Biorestorative Therapies -3,093.61%-129.47%-86.02% SummaryBiorestorative Therapies beats OpGen on 10 of the 14 factors compared between the two stocks. Get Biorestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRTX vs. The Competition Export to ExcelMetricBiorestorative TherapiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.56M$2.90B$5.51B$9.31BDividend YieldN/A2.46%4.25%4.09%P/E Ratio-1.0820.3628.1219.69Price / Sales29.81298.74439.46100.25Price / CashN/A42.3835.5357.53Price / Book1.297.768.235.67Net Income-$8.98M-$55.11M$3.23B$257.51M7 Day Performance-0.63%0.19%-0.52%-0.16%1 Month Performance-7.56%10.80%6.71%9.89%1 Year Performance-5.36%-0.68%27.10%15.08% Biorestorative Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRTXBiorestorative Therapies3.5695 of 5 stars$1.59+3.3%$18.00+1,032.1%-9.1%$11.56M$400K-1.087News CoverageOPGNOpGenN/A$4.93-1.8%N/A+49.3%$49.64M$2.67M0.00100Gap DownPIIIP3 Health Partners3.2266 of 5 stars$6.15-3.9%$16.25+164.2%-77.5%$44.21M$1.49B-0.13500Positive NewsBDSXBiodesix4.0665 of 5 stars$0.30+8.3%$1.75+485.9%-82.7%$43.78M$71.32M-1.03220BNRBurning Rock Biotech1.1177 of 5 stars$3.70+3.9%N/A-35.6%$39.81M$70.67M-1.961,390News CoverageBMGLBasel Medical GroupN/A$1.81-5.7%N/AN/A$33.40M$10.00M0.0036Positive NewsGap UpCCMConcord Medical Services0.772 of 5 stars$5.79+3.0%N/A-35.4%$25.13M$52.60M0.00970News CoverageMRAIMarpaiN/A$1.22-3.9%N/A+103.8%$20.17M$34.87M-0.46150ENZEnzo BiochemN/A$0.33-14.8%N/A-71.7%$17.03M$29.09M0.00520High Trading VolumeBGLCBioNexus Gene Lab1.2739 of 5 stars$6.40+7.9%N/A-18.3%$11.52M$9.51M0.0030MGRXMangoceuticals0.9806 of 5 stars$1.54+5.5%N/A-98.5%$7.96M$511.08K-0.333 Related Companies and Tools Related Companies OpGen Competitors P3 Health Partners Competitors Biodesix Competitors Burning Rock Biotech Competitors Basel Medical Group Competitors Concord Medical Services Competitors Marpai Competitors Enzo Biochem Competitors BioNexus Gene Lab Competitors Mangoceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BRTX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biorestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biorestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BRTX Stock Alerts